Best CGM for Type 1 Diabetes in 2026: 6 Devices Ranked by Accuracy

Type 1 diabetes requires 24/7 glucose monitoring because the pancreas produces little to no insulin, making blood sugar regulation entirely dependent on exogenous insulin and real-time data. A continuous glucose monitor is the standard of care for T1D management in 2026, recommended by the American Diabetes Association for all patients on intensive insulin therapy. The right CGM for type 1 diabetes must have real-time alerts for dangerous highs and lows, insulin pump compatibility for closed-loop automated delivery, and a MARD below 9% to support accurate dosing decisions.

The DIAMOND trial demonstrated that CGM use in T1D patients reduces A1C by 0.6% compared to fingerstick monitoring alone, while the IMPACT trial showed CGM reduces time in hypoglycemia by 38%. For type 1 diabetes patients, predictive low glucose alerts are a critical safety feature that prevents severe hypoglycemic events before they occur. The Dexcom G7 offers predictive urgent low alerts at 55 mg/dL and integrates with Omnipod 5, Tandem t:slim X2, and Tandem Mobi insulin pumps for automated insulin delivery. The FreeStyle Libre 3 Plus provides the most accurate readings at 7.9% MARD but currently lacks insulin pump integration.

For most type 1 diabetes patients, the Dexcom G7 or G7 15-Day is the top recommendation due to its insulin pump compatibility, predictive alerts, and 30-minute warmup time. Patients who prioritize raw accuracy and lower cost over pump integration should consider the FreeStyle Libre 3 Plus. The Eversense 365 is ideal for T1D patients who experience adhesive allergies or want to eliminate sensor changes entirely, though it requires twice-daily fingerstick calibration.